Diaceutics PLC (DXRX) — Cash Flow Reinvestment Rate
Diaceutics PLC (DXRX) has a Cash Flow Reinvestment Rate of 0.02x as of December 2025, reinvesting GBX16.00K (capex GBX16.00K ) from operating cash flow of GBX696.00K. See cash generation quality of Diaceutics PLC to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Diaceutics PLC Cash Flow Reinvestment Rate (2016–2025)
Historical reinvestment intensity for Diaceutics PLC across 8 annual periods. For the full cash flow conversion analysis, see how efficiently does Diaceutics PLC generate cash.
Annual Cash Flow Reinvestment Rate for Diaceutics PLC (2016–2025)
Year-by-year capital reinvestment analysis for Diaceutics PLC. See Diaceutics PLC financial flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (GBX) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.05x | GBX71.00K | GBX1.50 Million | GBX71.00K | ▼ -99.6% |
| 2024 | 13.31x | GBX8.66 Million | GBX651.00K | GBX4.63 Million | ▲ +92.5% |
| 2023 | 6.91x | GBX9.06 Million | GBX1.31 Million | GBX4.86 Million | ▲ +265.9% |
| 2022 | 1.89x | GBX9.63 Million | GBX5.10 Million | GBX4.87 Million | ▼ -90.4% |
| 2021 | 19.65x | GBX11.20 Million | GBX570.00K | GBX5.60 Million | ▼ -60.5% |
| 2020 | 49.75x | GBX12.59 Million | GBX253.00K | GBX6.29 Million | ▲ +13390.3% |
| 2017 | 0.37x | GBX565.83K | GBX1.53 Million | GBX282.92K | ▲ +328.4% |
| 2016 | 0.09x | GBX58.03K | GBX674.01K | GBX29.03K | — |